1. Home
  2. PMCB vs VS Comparison

PMCB vs VS Comparison

Compare PMCB & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.72

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo Versus Systems Inc.

VS

Versus Systems Inc.

HOLD

Current Price

$1.65

Market Cap

9.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
VS
Founded
1996
2013
Country
United States
United States
Employees
N/A
5
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
9.3M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PMCB
VS
Price
$0.72
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
85.4K
54.4K
Earning Date
03-17-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
277.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.75
52 Week High
$1.51
$2.81

Technical Indicators

Market Signals
Indicator
PMCB
VS
Relative Strength Index (RSI) 41.61 62.11
Support Level $0.65 $1.10
Resistance Level $0.78 $1.74
Average True Range (ATR) 0.05 0.15
MACD -0.01 0.03
Stochastic Oscillator 11.79 62.50

Price Performance

Historical Comparison
PMCB
VS

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About VS Versus Systems Inc.

Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.

Share on Social Networks: